Cargando…
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
25–30% of families fulfilling the criteria for hereditary diffuse gastric cancer have germline mutations of the CDH1 (E-cadherin) gene. In light of new data and advancement of technologies, a multidisciplinary workshop was convened to discuss genetic testing, surgery, endoscopy and pathology reporti...
Autores principales: | Fitzgerald, Rebecca C, Hardwick, Richard, Huntsman, David, Carneiro, Fatima, Guilford, Parry, Blair, Vanessa, Chung, Daniel C, Norton, Jeff, Ragunath, Krishnadath, Van Krieken, J Han, Dwerryhouse, Sarah, Caldas, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991043/ https://www.ncbi.nlm.nih.gov/pubmed/20591882 http://dx.doi.org/10.1136/jmg.2009.074237 |
Ejemplares similares
-
A short guide to hereditary diffuse gastric cancer
por: Guilford, Parry, et al.
Publicado: (2007) -
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
por: van der Post, Rachel S, et al.
Publicado: (2015) -
Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009) -
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status
por: Mi, Emma Z., et al.
Publicado: (2018) -
Non-targeted biopsies in hereditary diffuse gastric cancer: Necessary, but not enough
por: Buckley, Kole H., et al.
Publicado: (2023)